Alvotech (ALVO) EBITDA Margin (2022 - 2025)

Alvotech (ALVO) reported EBITDA Margin of 56.66% for Q4 2025, up 40948.0% on a YoY basis from N/an in Q4 2024, and up 105.99% quarter-over-quarter from 945.52% in Q3 2025.

Alvotech (ALVO) EBITDA Margin (2022 - 2025) Analysis & Trends

Alvotech has reported EBITDA Margin for 4 years, with the latest figure at 56.66% in Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin rose 40948.0% year-over-year to 56.66%; the trailing twelve-month figure through Dec 2025 stood at 51.22% (up 15303.0% YoY), and the FY2025 full-year result was 28.31%, up 284.0% from the prior year.
  • EBITDA Margin for Q4 2025 stood at 56.66%, up from 945.52% in the prior quarter.
  • The five-year high for EBITDA Margin was 7637.27% in Q2 2022, with the low at 17049.34% in Q1 2022.
  • Historically, EBITDA Margin has averaged 1262.38% across 4 years, with a median of 100.5% in 2025.
  • The largest YoY upside for EBITDA Margin was 1704933 bps in 2023 against a maximum downside of 763783 bps in 2023.
  • Alvotech's EBITDA Margin stood at 3772.44% in 2022, then increased by 23 bps to 2919.82% in 2023, then jumped by 88 bps to 352.82% in 2024, then jumped by 116 bps to 56.66% in 2025.
  • The last three EBITDA Margin figures came in at 56.66% (Q4 2025), 945.52% (Q3 2025), and 384.6% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 16.37%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 36.83%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 41.69%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -1.01%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 22.74%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 22.39%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -170.35%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -16.25%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 21.55%
10 Alvotech 12.16 Mn -160.20 Mn -22.39 Mn 56.66%

Historic Data

Download Data
DateValue
Dec 31, 2025 56.66%
Sep 30, 2025 -945.52%
Jun 30, 2025 384.60%
Mar 31, 2025 -199.76%
Dec 31, 2024 -352.82%
Sep 30, 2024 -510.31%
Jun 30, 2024 -1.24%
Mar 31, 2024 0.00%
Dec 31, 2023 -2,919.82%
Jun 30, 2023 -0.56%
Mar 31, 2023 0.00%
Dec 31, 2022 -3,772.44%
Jun 30, 2022 7,637.27%
Mar 31, 2022 -17,049.34%